About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
539
By Phase
PHASE2: 4PHASE1/PHASE2: 1PHASE1: 3
By Status
COMPLETED: 6NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06487000Lead Sponsor
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
PHASE2Not yet recruiting
150 participants
Started: May 31, 2025 · Completed: Dec 31, 2026
NCT04569227Lead Sponsor
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
PHASE2Unknown
60 participants
Started: Apr 30, 2021 · Completed: Nov 30, 2021
NCT04500132Lead Sponsor
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
PHASE2Completed
63 participants
Started: May 28, 2020 · Completed: Feb 15, 2021
NCT03200340Lead Sponsor
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
PHASE2Completed
105 participants
Started: Jul 3, 2018 · Completed: May 14, 2021
NCT03104595Lead Sponsor
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
PHASE1/PHASE2Completed
28 participants
Started: Oct 30, 2017 · Completed: Dec 5, 2019
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...